合計: 5 |
|
PMID (PMCID) | ||
---|---|---|
12571475 |
FEMALE | Infant |
Hypercalcemia in Langerhans cell histiocytosis: is it therapy-related? | ||
Jubinsky PT. J Pediatr Hematol Oncol. 2003;25(2):176-9. |
||
Hypercalcemia is not known to be a common occurrence in patients with Langerhans cell histiocytosis (LCH). | ||
11792606 |
FEMALE | Middle Aged |
Hypercalcemia in Langerhans' cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level. | ||
Al-Ali H, Yabis AA, Issa E, Salem Z, Tawil A, Khoury N, Fuleihan Gel-H. Bone. 2002;30(1):331-4. |
||
Whereas hypercalcemia has been described in several granulomatous disorders and is secondary to unregulated extrarenal production of 1,25 dihydroxyvitamin D, it is, however, extremely rare in Langerhans' cell granulomatosis. | ||
11792606 |
FEMALE | Middle Aged |
Hypercalcemia in Langerhans' cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level. | ||
Al-Ali H, Yabis AA, Issa E, Salem Z, Tawil A, Khoury N, Fuleihan Gel-H. Bone. 2002;30(1):331-4. |
||
This is the first case report of Langerhans' cell granulomatosis with hypercalcemia and documented elevated increased 1,25 dihydroxyvitamin D level that responded to the treatment of her primary disease. | ||
11792606 |
FEMALE | Middle Aged |
Hypercalcemia in Langerhans' cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level. | ||
Al-Ali H, Yabis AA, Issa E, Salem Z, Tawil A, Khoury N, Fuleihan Gel-H. Bone. 2002;30(1):331-4. |
||
Hypercalcemia in Langerhans' cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level. | ||
8689352 |
MALE | Infant |
Langerhans cell histiocytosis and hypercalcemia: clinical response to indomethacin. | ||
McLean TW, Pritchard J. J Pediatr Hematol Oncol. 1996;18(3):318-20. |
||
Langerhans cell histiocytosis and hypercalcemia: clinical response to indomethacin. |